White Paper – The Business Case for a Circular MedTech Sector

In Insights

15 April, 2021

This whitepaper demonstrates that the efforts of private companies towards circularity can in fact lead to a more sustainable medtech sector. Sustainable solutions in the field have the potential to not only reduce greenhouse gas emissions, but importantly also address a range of issues related to pollution and waste.

The effects should benefit natural environments and human health alike, and bring the industry in line with the scope of international agreements on sustainability such as the Paris Agreement of 2015. The move towards circularity constitutes a solid business case for competitive medtech companies.

This whitepaper is a result of a joint effort between AWA, Green Innovation Group and Matter.

The Business Case for a Circular MedTech Sector

Download White Paper

Send download link to:

You may also be interested in:

EPO’s highest legal authority to decide if post-published data can support inventive step

The European Patent Office’s (EPO) highest legal authority, the Enlarged Board of Appeal, is about to be referred questions

Read more...

The Business of IP – Understanding and Creating Value: Part 4 – Spin-Offs

In this six-part series, Anders Isaksson explores some of the critical factors and motivators for why companies, small or

Read more...

Was this the last hurdle for German UPCA Ratification?

At the end of 2020, German ratification of the Agreement on a Unified Patent Court (UPCA) looked promising as

Read more...

Mobile Sliding Menu